Skip to menu Skip to content Skip to footer
Dr Kim Bridle
Dr

Kim Bridle

Email: 
Phone: 
+61 7 334 60698

Overview

Background

Dr Kim Bridle is currently Senior Research Officer within the Greenslopes Clinical Unit, Faculty of Medicine. Her current research focuses on liver disease treatment and pathogenesis with a focus on hepatic fibrosis, metabolic fatty liver disease and liver cancer. Dr Bridle has made important contributions to the understanding of diseases associated with altered iron metabolism and mechanisms of hepatic fibrosis.

Dr Bridle currently serves on the Research and Grants Committee of the Gastroenterological Society of Australia and is a member of the Ramsay Health Care Human Research Ethics Committee. Dr Bridle is a Section Editor for the journal, BioMed Research International.

Availability

Dr Kim Bridle is:
Available for supervision

Fields of research

Qualifications

  • Bachelor of Science, The University of Queensland
  • Doctor of Philosophy, The University of Queensland

Works

Search Professor Kim Bridle’s works on UQ eSpace

139 works between 1995 and 2023

81 - 100 of 139 works

2009

Journal Article

Hepcidin regulation in wild-type and Hfe knockout mice in response to alcohol consumption: Evidence for an alcohol-induced hypoxic response

Heritage, Mandy L., Murphy, Therese L., Bridle, Kim R., Anderson, Gregory J., Crawford, Darrell H. G. and Fletcher, Linda M. (2009). Hepcidin regulation in wild-type and Hfe knockout mice in response to alcohol consumption: Evidence for an alcohol-induced hypoxic response. Alcoholism, Clinical and Experimental Research, 33 (8), 1391-1400. doi: 10.1111/j.1530-0277.2009.00969.x

Hepcidin regulation in wild-type and Hfe knockout mice in response to alcohol consumption: Evidence for an alcohol-induced hypoxic response

2009

Conference Publication

The antifibrotic effect of low dose rapamycin is diminished in Mdr2-/- when administered to animals with advanced hepatic fibrosis

Sobbe, AL, Bridle, KR and Crawford, DHG (2009). The antifibrotic effect of low dose rapamycin is diminished in Mdr2-/- when administered to animals with advanced hepatic fibrosis. Australia & New Zealand Medical & Surgical Gastrointestinal Week 2009, Sydney, Australia, 21-24 October 2009. MALDEN: WILEY-BLACKWELL PUBLISHING, INC.

The antifibrotic effect of low dose rapamycin is diminished in Mdr2-/- when administered to animals with advanced hepatic fibrosis

2008

Conference Publication

Rapamycin as an inhibitor of hepatic fibrosis: relevance to whole blood levels

Popa, C., Bridle, K. R., Morgan, M. L., Clouston, A. D., Fletcher, L. M. and Crawford, D. H. G. (2008). Rapamycin as an inhibitor of hepatic fibrosis: relevance to whole blood levels. 43rd Annual Meeting of the European Association for the Study of the Liver, Milan, Italy, 23-27 April, 2008. Ireland: Elsevier. doi: 10.1016/S0168-8278(08)60467-5

Rapamycin as an inhibitor of hepatic fibrosis: relevance to whole blood levels

2008

Conference Publication

Multiple pathways to hepatic fibrosis are inhibited by rapamycin

Bridle, K. R., Sobbe, A. L., Fletcher, L. M., Clouston, A. D. and Crawford, D. H. G. (2008). Multiple pathways to hepatic fibrosis are inhibited by rapamycin. Australian Gastroenterology Week 2008, Brisbane, Qld, Australia, 22-25 October 2008. Carlton South, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2008.05613.x

Multiple pathways to hepatic fibrosis are inhibited by rapamycin

2008

Conference Publication

Hepcidin regulation in wild-type and HFE-/mice in response to alcohol consumption: Evidence for an alcohol-induced hypoxic response

Fletcher, L. M., Heritage, M. L., Murphy, T. L., Bridle, K. R., Anderson, G. J. and Crawford, D. H. (2008). Hepcidin regulation in wild-type and HFE-/mice in response to alcohol consumption: Evidence for an alcohol-induced hypoxic response. 43rd Annual Meeting of the European Association for the Study of the Liver, Milan, Italy, 23-27 April, 2008. Copenhagen, Denmark: Elsevier. doi: 10.1016/S0168-8278(08)60888-0

Hepcidin regulation in wild-type and HFE-/mice in response to alcohol consumption: Evidence for an alcohol-induced hypoxic response

2008

Conference Publication

Hepcidin regulation in response to alcohol consumption: evidence for an alcohol-induced hypoxic response

Heritage, M. L., Jaskowski, L. A., Bridle, K. R., Murphy, T. L., Anderson, G. J., Crawford, D. H. and Fletcher, L. M. (2008). Hepcidin regulation in response to alcohol consumption: evidence for an alcohol-induced hypoxic response. Australian Gastroenterology Week, Brisbane, Qld, Australia, 22-25 October, 2008. Carlton South, Vic, Australia: Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2008.05613.x

Hepcidin regulation in response to alcohol consumption: evidence for an alcohol-induced hypoxic response

2008

Conference Publication

Hepcidin regulation in wild-type and Hfe(-/-) mice in response to alcohol consumption: Evidence for an alcohol-induced hypoxic response

FletcherLM, Heritage, ML, MurphyTL, BridleKR, AndersonGJ and CrawfordDH (2008). Hepcidin regulation in wild-type and Hfe(-/-) mice in response to alcohol consumption: Evidence for an alcohol-induced hypoxic response. 43rd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Milan ITALY, APR 23-27, 2008. doi: 10.1016/S0168-8278(08)60888-0

Hepcidin regulation in wild-type and Hfe(-/-) mice in response to alcohol consumption: Evidence for an alcohol-induced hypoxic response

2007

Conference Publication

Hepciden gene expression is further suppressed in Hfe-/- mice following chronic ethanol consumption

Fletcher, L. M., Heritage, M. L., Murphy, T. L., Bridle, K. R., Anderson, G. J. and Crawford, D. H. G. (2007). Hepciden gene expression is further suppressed in Hfe-/- mice following chronic ethanol consumption. 2007 International BioIron Society Meeting, Kyoto, Japan, 1-6 April, 2007. New York: Wiley-LISS. doi: 10.1002/ajh.20964

Hepciden gene expression is further suppressed in Hfe-/- mice following chronic ethanol consumption

2007

Conference Publication

Rapamycin as an anti-fibrotic agent

Popa, C., Bridle, K. R., Morgan, M. L., Robinson, M. W., Fletcher, L. M. and Crawford, D. H. (2007). Rapamycin as an anti-fibrotic agent. Australian Gastroenterology Week, Perth, Australia, 24-27 October 2007. Australia. doi: 10.1111/j.1440-1746.2007.05161.x

Rapamycin as an anti-fibrotic agent

2007

Journal Article

Hepcidin gene expression is further suppressed in HFE-/-mice following chronic ethanol consumption

Fletcher, LM, Heritage, ML, Bridle, KR, Murphy, TL, Anderson, GJ and Crawford, DH (2007). Hepcidin gene expression is further suppressed in HFE-/-mice following chronic ethanol consumption. American Journal of Hematology, 82 (6), 528-529.

Hepcidin gene expression is further suppressed in HFE-/-mice following chronic ethanol consumption

2007

Journal Article

Effect of phorbol ester and platelet-derived growth factor on protein kinase C in rat hepatic stellate cells

Kobayashi, Yoshimasa, Bridle, Kim R., Ramm, Grant A., O'Neill, Rosemary, Britton, Robert S. and Bacon, Bruce R. (2007). Effect of phorbol ester and platelet-derived growth factor on protein kinase C in rat hepatic stellate cells. Liver International, 27 (8), 1066-1075. doi: 10.1111/j.1478-3231.2007.01573.x

Effect of phorbol ester and platelet-derived growth factor on protein kinase C in rat hepatic stellate cells

2007

Conference Publication

Alcohol consumption further modulates hepcidin gene expression in an animal model of hemochromatosis

Heritage, M. L., Murphy, T. L., Popa, C., Bridle, K. R., Anderson, G. J., Crawford, D. H. G. and Fletcher, L. M. (2007). Alcohol consumption further modulates hepcidin gene expression in an animal model of hemochromatosis. Australian Gastroenterology Week 2007, Perth, Australia, 24–27 October 2007. Melbourne, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2007.05161.x

Alcohol consumption further modulates hepcidin gene expression in an animal model of hemochromatosis

2007

Conference Publication

Alcohol consumption further modulates hepcidin gene expression in an animal model of hemochromatosis

Fletcher, L. M., Heritage, M. L., Murphy, T. L., Popa, C., Bridle, K. R., Anderson, G. J. and Crawford, D. H. (2007). Alcohol consumption further modulates hepcidin gene expression in an animal model of hemochromatosis. 58th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, Massachusetts, U.S.A., 1-6 November 2007. U.S.A.: Wiley InterScience. doi: 10.1002/hep.22022

Alcohol consumption further modulates hepcidin gene expression in an animal model of hemochromatosis

2006

Conference Publication

Von Willebrand factor expression in relation to cirrhosis development in a rat model of fibrogenesis

Bridle, K. R., Patella, S., Tchongue, J., Fletcher, L. M., Sievert, W. and Crawford, D. H. G. (2006). Von Willebrand factor expression in relation to cirrhosis development in a rat model of fibrogenesis. Australian Gastroenterology Week 2006, Adelaide, South Australia, 11-14 October, 2006. Carlton South, Vic. Australia: Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2006.04689.x

Von Willebrand factor expression in relation to cirrhosis development in a rat model of fibrogenesis

2006

Conference Publication

Von Willebrand factor expression in relation to cirrhosis development in a rat model of fibrogenesis

Bridle, K. R., Patella, S., Tchongue, J., Fletcher, L. M., Sievert, W. and Crawford, D. H. G. (2006). Von Willebrand factor expression in relation to cirrhosis development in a rat model of fibrogenesis. Australian Gastroenterology Week, Adelaide, Australia, 11–14 October 2006. Oxford United Kingdom: Wiley.

Von Willebrand factor expression in relation to cirrhosis development in a rat model of fibrogenesis

2006

Journal Article

Coordinate activation of intracellular signaling pathways by insulin-like growth factor-1 and platelet-derived growth factor in rat hepatic stellate cells

Bridle, K. R., Li, L., O'Neill, R., Britton, R. S. and Bacon, B. R. (2006). Coordinate activation of intracellular signaling pathways by insulin-like growth factor-1 and platelet-derived growth factor in rat hepatic stellate cells. The Journal of Laboratory and Clinical Medicine, 147 (5), 234-241. doi: 10.1016/j.lab.2005.12.009

Coordinate activation of intracellular signaling pathways by insulin-like growth factor-1 and platelet-derived growth factor in rat hepatic stellate cells

2006

Conference Publication

Post liver transplantation disease recurrence: influence of matrix degradation proteins

Bridle, K. R., Murphy, T. L., Fletcher, L. M. and Crawford, D. H. G. (2006). Post liver transplantation disease recurrence: influence of matrix degradation proteins. Australian Gastroenterology Week 2006, Adelaide, South Australia, 11-14 October, 2006. Carlton South, Vic. Australia: Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2006.04689.x

Post liver transplantation disease recurrence: influence of matrix degradation proteins

2006

Journal Article

Hepcidin is down-regulated in alcoholic liver injury: Implications for the pathogenesis of alcoholic liver disease

Bridle, Kim R., Cheung, Ting-Kin, Murphy, Therese L., Walters, Margaret M., Anderson, Gregory J., Crawford, Darrell H. G. and Fletcher, Linda M. (2006). Hepcidin is down-regulated in alcoholic liver injury: Implications for the pathogenesis of alcoholic liver disease. Alcoholism-clinical And Experimental Research, 30 (1), 106-112. doi: 10.1111/j.1530-0277.2006.00002.x

Hepcidin is down-regulated in alcoholic liver injury: Implications for the pathogenesis of alcoholic liver disease

2006

Conference Publication

Very low dose rapamycin : In vitro evidence for its use as an antifibrotic agent

Morgan, M. L., Bridle, K. R., Fletcher, L. M. and Crawford, D. H. G. (2006). Very low dose rapamycin : In vitro evidence for its use as an antifibrotic agent. Australian Gastroenterology Week, Adelaide, SA, Australia, 11-14 October 2006. Richmond, Vic., Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2006.04689.x

Very low dose rapamycin : In vitro evidence for its use as an antifibrotic agent

2006

Conference Publication

Serum adiponectin is increased in HFE-/- mice fed alcohol

Bridle, K. R., Murphy, T. L., Anderson, G. J., Macdonald, G. A., Crawford, D. H. G. and Fletcher, L. M. (2006). Serum adiponectin is increased in HFE-/- mice fed alcohol. Australian Gastroenterology Week 2006, Adelaide, South Australia, 11-14 October, 2006. Carlton South, Vic. Australia: Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2006.04689.x

Serum adiponectin is increased in HFE-/- mice fed alcohol

Funding

Current funding

  • 2014 - 2024
    Liver Disease Research
    Gallipoli Medical Research Foundation
    Open grant

Past funding

  • 2014 - 2019
    Immunotherapeutic Approaches for Hepatocellular Carcinoma
    Gallipoli Medical Research Foundation
    Open grant
  • 2013
    Targeting Pathophysiology & therapy of liver fibrosis
    Gallipoli Research Foundation
    Open grant
  • 2011 - 2013
    Targeting the Pathophysiology and Therapy of Liver Fibrosis
    NHMRC Project Grant
    Open grant
  • 2008 - 2009
    Reginald Ferguson Fellowship - Rapamycin as an Antifibrotic Agent in Cholestatic Liver Disease
    Ferguson Foundation (Reginald Ferguson)
    Open grant
  • 2007 - 2010
    The pathogenesis of co-toxic liver disease
    Queensland Health Smart Health Research Grant
    Open grant
  • 2006 - 2008
    Reginald Ferguson Research Fellowship - Primary Sclerosing Cholangitis - A Life Threatening Complication of Inflammatory Bowel Disease: Investigations to Attenuate Disease Progression
    Ferguson Foundation (Reginald Ferguson)
    Open grant
  • 2006 - 2007
    The use of rapamycin to slow scarring of the liver
    Royal Children's Hospital Foundation
    Open grant
  • 2006 - 2009
    Immunosuppressant-Mediated Changes in Extracellular Matrix Balance in Animal Models of Liver Disease
    Princess Alexandra Hospital R&D Foundation
    Open grant
  • 2005 - 2007
    Does immunosuppression affect the post-transplantation hepatic fibrogenic response?
    NHMRC Project Grant
    Open grant
  • 2005
    The Influence of Immunosuppression on the Hepatic Stellate Cell Fibrogenic Response
    UQ Early Career Researcher
    Open grant
  • 2004 - 2007
    Pathogenic mechanisms underlying iron co-toxicity in chronic liver disease
    Gastroenterological Society of Australia
    Open grant

Supervision

Availability

Dr Kim Bridle is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Available projects

  • Novel Therapies for Co-toxic Liver Disease

    This project will examine the pathogenesis of co-toxic liver disease and will study the restoration of iron homeostasis as a potential therapeutic application in liver diseases associated with altered iron metabolism.

Supervision history

Current supervision

Completed supervision

Media

Enquiries

For media enquiries about Dr Kim Bridle's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au